Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

MediXall (MDXL) Depreciation & Amortization (CF) (2020 - 2024)

MediXall's Depreciation & Amortization (CF) history spans 5 years, with the latest figure at $761.0 for Q3 2024.

  • For Q3 2024, Depreciation & Amortization (CF) fell 41.33% year-over-year to $761.0; the TTM value through Sep 2024 reached $3950.0, down 53.25%, while the annual FY2023 figure was $8267.0, 175.57% up from the prior year.
  • Depreciation & Amortization (CF) reached $761.0 in Q3 2024 per MDXL's latest filing, down from $903.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $4460.0 in Q1 2023 to a low of -$2059.0 in Q3 2022.
  • Average Depreciation & Amortization (CF) over 5 years is $1159.0, with a median of $1000.0 recorded in 2020.
  • The largest YoY upside for Depreciation & Amortization (CF) was 761.88% in 2022 against a maximum downside of 305.9% in 2022.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $1000.0 in 2020, then tumbled by 84.0% to $160.0 in 2021, then skyrocketed by 761.88% to $1379.0 in 2022, then decreased by 13.27% to $1196.0 in 2023, then tumbled by 36.37% to $761.0 in 2024.
  • Per Business Quant, the three most recent readings for MDXL's Depreciation & Amortization (CF) are $761.0 (Q3 2024), $903.0 (Q2 2024), and $1090.0 (Q1 2024).